kras mutation and glutathion Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase glutathione biosynthesis KRAS G12V mutation-selective requirement for
KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab KRAS Screening and Profiling Services
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




